01 1Contrave
02 6Wellbutrin
03 3Wellbutrin?
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 281
2019 Revenue in Millions : 269
Growth (%) : 4
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 271
2019 Revenue in Millions : 244
Growth (%) : 11
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 254
2020 Revenue in Millions : 271
Growth (%) : -6
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 264
2020 Revenue in Millions : 281
Growth (%) : -6
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 269
2018 Revenue in Millions : 263
Growth (%) : 2
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 244
2018 Revenue in Millions : 252
Growth (%) : -3
Main Therapeutic Indication : Weight Loss and Obesity
Currency : USD
2016 Revenue in Millions : 39
2015 Revenue in Millions : 62
Growth (%) : -38
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 279
2015 Revenue in Millions : 306
Growth (%) : -9
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 234
2016 Revenue in Millions : 279
Growth (%) : -16
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 252
2017 Revenue in Millions : 235
Growth (%) : 7%
LOOKING FOR A SUPPLIER?